🇪🇺 Gbt021601 in European Union

Gbt021601 (gbt021601) regulatory status in European Union.

Marketing authorisation

EMA

  • Status: approved

Gbt021601 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Rare Disease approved in European Union

Frequently asked questions

Is Gbt021601 approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for Gbt021601 in European Union?

Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.